Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Lexapro improves MDD symptoms in adolescents

Forest (FRX) and H. Lundbeck (CSE:LUN) said preliminary data from a

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE